fda and compounded semaglutide Novo asks to prevent compounders from making GLP-1 knockoffs FDA ends semaglutide shortage, closing

It includes multiple trials studying retatrutide in different patient populations and for different indications

Poll: 1 in 8 adults say they are currently taking a GLP-1 drug for weight loss, diabetes, or another condition, even as half say the drugs are difficult to afford, KFF (2025) The relationship between dietary habits and menstruation problems in women: a cross-sectional study, BMC Womens Health (2024) Systemic inflammation and menstrual cycle length in a prospective cohort study, American Journal of Obstetrics & Gynecology (2023) Do GLP-1 weight loss drugs affect the menstrual cycle

I had binging episodes I had not had since before starting GLP-1

In contrast, it is less clear whether the circumventricular organs are projection targets for PPG neurons

Clinical trials have demonstrated Mounjaro's substantial efficacy in type 2 diabetes

The high proportion of fat reduction within overall weight loss indicates that the risk of muscle loss accompanying weight reduction was minimized